Læknablaðið - 01.02.1977, Blaðsíða 42

18
LÆKNABLAÐIÐ
9. Bloofield, T. H. Australia antigen in V.D.
clinic patients. Brit. Med. J. 2:779. 1973.
10. Blumberg, B. S. Polymorphisms of serum
proteins and the development of isopre-
cipitins in transfused patients. Bull. N.Y.
Acad. Med. 40:377. 1964.
11. Blumberg, B. S., Alter, J. H., Visnich, S.
A “new” antigen in leukaemia sera. J.
Amer. Med. Ass. 191:541. 1965.
12. Blumberg, B. S., Sutnick, A. L., London,
W. T. Hepatitis and leukaemia. Their re-
lation to Australia antigen. Bull. N.Y. Acad.
Med. 44:1566. 1968.
13. Brzosko, W. J. et al. Glomerulonephritis
associated with hepatitis-B surface antigen
immune complexes in children. Lancct
2:477. 1974.
14. Buchholz, H. M. et al. HBAg carrier state
in an infant delivered by Caesarean section.
Lancet 2:343. 1974.
15. Chalmers, T. C. Viral hepatitis can largely
be prevented. 1 Liver (ed. S. J. Saunder,
J. Terblanche) bls. 37-44. Pitman Medical.
London 1973.
16. Chrystie, I. L. et al. Clinical evaluation of
the Turkey erythrocyte passive-haemag-
glutination Test for hepatitis-B surface
antigen. Lancet 1:1193. 1974.
17. Cossart, Y. E. Epidemiology of serum hepa-
titis. Brit. Med. Bull. 2S:156. 1972.
18. Dane, D. S., Cameron, C. H., Briggs, M.
Virus-like particles in serum of patients
with Australia antigen associated hepatitis.
Lancet 1:695. 1970.
19. Darani, M., Gerber, M. Hepatitis-B antigen
in vaginal secretions. Lancet 2:1008. 1974.
20. Del Prete, S., Constantino, D., Doglia, M.
Different Australia-antigen determinants in
acut viral hepatitis. Lancet 2:292. 1970.
21. Dudley, F. J., Fox, R. A„ Sherlock, S. Re-
lationship of hepatitis associated antigen
(HAA) to acute and chronic liver injury.
Lancet 2:1. 1971.
22. Dudley, F. J., Fox, R. A., Sherlock, S.
Cellular immunity and hepatitis associated
Australia antigen liver disease. Lancet
1:723. 1972.
23. Dupuy, J. M. et al. Severe virai hepatitis
type B in infancy. Lancet 1:191. 1975.
24. Eddleston, A. L. W. F., Williams, R. In-
adequate antibody response to HBAg or
sunoressor T-cell defect in development of
active chronic hepatitis. Lancet 2:1543.
1974.
25. Feinman. S. V., Berris, B., Sinclair, J. C.,
Wrobel, D. M„ Alter, H. J„ Holland, P. V.
Relation of hepatitis-B-antigen subtypes in
svmDtom-free carriers to geographical
origin and liver abnormalities. Lancet 2:867.
1973.
26. Feinstone. S. M„ Kapikian, A. Z„ Purcell,
R. H. Hepatitis-A: Detection by immune
o'eetron microscopy of a viruslike antigen
a.ssociated with acute illness. Science 182:
1026. 1973.
27. Fulford, K. W. M., Dane, D. S. et al.
Australia antigen and antibody among pati-
ents attending a clinic for sexually trans-
mitted diseases. Lancet 1:1470. 1973.
28. Giles, J. P., Mc. Collum, R. W., Berndtson,
L. W„ Krugman, S. Viral hepatitis: Relation
of Australia/SH antigen to the Willow-
brook MS-2 strain. New Engl. J. Med.
281:119. 1969.
29. Gillespie, A. et al. Neonatal hepatitis and
Australia antigen. Lancet 2:1081. 1970.
30. Gocke, D. J., Kavey, N. B. Hepatitis antigen
correlation with disease and infectivity of
blood-donors. Lancet 1:1055. 1969.
31. Gocke, D. J„ Howe, C. Rapid detection of
Australia antigen by counter-immuno-
electrophoresis. J. Immunol. 104:1031. 1970.
32. Gocke, D. J., Hsu, K., Morgan, C. et al.
Association between polyarteritis and Aus-
tralia antigen. Lancet 2:1149. 1970.
33. Gocke, D. J. The current status of post-
transfusion hepatitis. Flutt á 5th World
Congress of Gastroenterology, Mexico City,
október 1974.
34. Gross, P. J., Jemelka, H. Faecal SH
(Australia) antigen in acute hepatitis.
Lancet 1:206. 1971.
35. Hasan Telatar et al. HBAg in sweat.
Lancet 2:461. 1974.
36. Heathcote, J., Sherlock, S. Spread of acute
type-B hepatitis in London. Lancet 1:1468
1973.
37. Heathcote, J., Cameron, C. H„ Dane, D. S.
Hepatitis-B antigen in saliva and semen.
Ltíncet 1:71. 1974.
38. Heathcote, J„ Gateau, Ph„ Sherlock, S.
R.ole of hepatitis-B antigen carriers in non-
parenteral transmission of the hepatitis-B
virus. Lancet 2:370. 1974.
39. Hepatitis and blood transfusion. Ed. G. N.
Vyas, H. A. Perkins, R. Schmid. Grune and
Stratton, New York 1972.
40. Hirschman, S. Z„ Vernace, S. J„ Schaffner,
F. DNA polymerase in preparations con-
taining Australia antigen. Lancet 1:1099.
1971.
41. Hoofnagle, J. H., Gerety, R. J., Ni, L. Y.,
Barker, L. F. Antibody to hepatitis-B core
antigen. N. Engl. J. Med. 290:1336. 1974.
42. Jozviak, W., Koscielak, J., Madeilinski, K„
Brzosko, W. J„ Nowoslawski, A., Kloczce-
wiak, M. R.N.A. of Australia antigen.
Nature New Biol. 229:92. 1971.
43. Kim, C. Y„ Bissel, D. M. Stability of the
lipid and protein of hepatitis associated
(Australia) antigen. J. Infect. Dis. 123:470.
1971.
44. Krugman, S., Hoofnagle, J. H„ Gerety,
R. J„ Kaplan. P. M., Gerin, J. L. Viral
henatitis type B, DNA polvmerase activity
and antibodv to hepatitis B core antigen.
N. Engl. J. 'Med. 290:1331. 1974.
45. L» Bouvier. G. Seroanalysis by immuno-
diffusion: The subtypes of type B hepatitis
virus. 1 Hepatitis and blood transfusion
(ed. G. N. Vyas, H. A. Perkins, R. Schmid)